PCVX Latest Press Releases

-- September 3, 2026 --

Vaxcyte Appoints Chief Medical Officer and Chief Legal Officer; Narrows Guidance for Expected VAX-31 OPUS-1 Topline Data Globe Newswire 4:05 PM

-- August 27, 2026 --

Vaxcyte to Participate in Upcoming Investor Conferences Globe Newswire 4:05 PM

-- August 5, 2026 --

Vaxcyte Reports Second Quarter 2026 Financial Results and Provides Business Update Globe Newswire 4:05 PM

-- July 8, 2026 --

Vaxcyte to Participate in Upcoming Investor Conferences Globe Newswire 4:05 PM

-- June 2, 2026 --

Vaxcyte Doses First Participant in Phase 1 Study Evaluating VAX-A1 for the Prevention of Disease Caused by Group A Streptococcus in Healthy Adults Globe Newswire 4:05 PM

-- May 6, 2026 --

Vaxcyte Reports First Quarter 2026 Financial Results and Provides Business Update Globe Newswire 4:05 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software